Abrahams NA - Search Results

1

Morphologic characterization of preoperatively treated prostate cancer: toward a post-therapy histologic classification.

Efstathiou E, Abrahams NA, Tibbs RF, Wang X, Pettaway CA, Pisters LL, Mathew PF, Do KA, Logothetis CJ, Troncoso P. Efstathiou E, et al. Among authors: abrahams na. Eur Urol. 2010 Jun;57(6):1030-8. doi: 10.1016/j.eururo.2009.10.020. Epub 2009 Oct 17. Eur Urol. 2010. PMID: 19853370 Free PMC article.

2

Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience.

Siefker-Radtke AO, Dinney CP, Abrahams NA, Moran C, Shen Y, Pisters LL, Grossman HB, Swanson DA, Millikan RE. Siefker-Radtke AO, et al. Among authors: abrahams na. J Urol. 2004 Aug;172(2):481-4. doi: 10.1097/01.ju.0000132413.85866.fc. J Urol. 2004. PMID: 15247709

3

Multilocular cystadenoma and cystadenocarcinoma of the prostate.

Tuziak T, Spiess PE, Abrahams NA, Wrona A, Tu SM, Czerniak B. Tuziak T, et al. Among authors: abrahams na. Urol Oncol. 2007 Jan-Feb;25(1):19-25. doi: 10.1016/j.urolonc.2006.01.011. Urol Oncol. 2007. PMID: 17208134 Review.

4

Clinical significance of benign glands at surgical margins in robotic radical prostatectomy specimens.

Kohl SK, Balaji KC, Smith LM, Wilson NP, Johansson SL, Sterrett SP, Abrahams NA. Kohl SK, et al. Among authors: abrahams na. Urology. 2007 Jun;69(6):1112-6. doi: 10.1016/j.urology.2007.02.048. Urology. 2007. PMID: 17572197 Clinical Trial.

5

Prognostic importance of resection margin width after nephron-sparing surgery for renal cell carcinoma.

Castilla EA, Liou LS, Abrahams NA, Fergany A, Rybicki LA, Myles J, Novick AC. Castilla EA, et al. Among authors: abrahams na. Urology. 2002 Dec;60(6):993-7. doi: 10.1016/s0090-4295(02)01983-0. Urology. 2002. PMID: 12475656

6

Small cell carcinoma of the bladder: a contemporary clinicopathological study of 51 cases.

Abrahams NA, Moran C, Reyes AO, Siefker-Radtke A, Ayala AG. Abrahams NA, et al. Histopathology. 2005 Jan;46(1):57-63. doi: 10.1111/j.1365-2559.2004.01980.x. Histopathology. 2005. PMID: 15656887

7

N-cadherin switching occurs in high Gleason grade prostate cancer.

Jaggi M, Nazemi T, Abrahams NA, Baker JJ, Galich A, Smith LM, Balaji KC. Jaggi M, et al. Among authors: abrahams na. Prostate. 2006 Feb 1;66(2):193-9. doi: 10.1002/pros.20334. Prostate. 2006. PMID: 16173043

8

Adenocarcinoma of the small bowel: a study of 37 cases with emphasis on histologic prognostic factors.

Abrahams NA, Halverson A, Fazio VW, Rybicki LA, Goldblum JR. Abrahams NA, et al. Dis Colon Rectum. 2002 Nov;45(11):1496-502. doi: 10.1097/01.DCR.0000034134.49346.5E. Dis Colon Rectum. 2002. PMID: 12432298

9

Chromophobe renal cell carcinoma with sarcomatoid transformation.

Abrahams NA, Ayala AG, Czerniak B. Abrahams NA, et al. Ann Diagn Pathol. 2003 Oct;7(5):296-9. doi: 10.1016/s1092-9134(03)00072-8. Ann Diagn Pathol. 2003. PMID: 14571432

10

Quantitative fluorescence imaging analysis for cancer biomarker discovery: application to beta-catenin in archived prostate specimens.

Huang D, Casale GP, Tian J, Wehbi NK, Abrahams NA, Kaleem Z, Smith LM, Johansson SL, Elkahwaji JE, Hemstreet GP 3rd. Huang D, et al. Among authors: abrahams na. Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1371-81. doi: 10.1158/1055-9965.EPI-06-0718. Epub 2007 Jul 10. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17623804

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page